(AGENPARL) – SILVER SPRING ven 21 aprile 2023 Plazomicin – Injection: FDA-Identified Interpretive Criteria Fonte/Source: http://www.fda.gov/drugs/development-resources/plazomicin-injection
Browsing: injection
(AGENPARL) – SILVER SPRING mar 18 aprile 2023 Rezafungin Injection Recognized Interpretive Criteria Fonte/Source: http://www.fda.gov/drugs/development-resources/rezafungin-injection
(AGENPARL) – SILVER SPRING mar 18 aprile 2023 Piperacillin Tazobactam – Injection products Fonte/Source: http://www.fda.gov/drugs/development-resources/piperacillin-tazobactam-injection-products
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 The recall, which began in October 2018, was originally initiated due to a…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 FDA CDER proposed that Makena (hydroxyprogesterone caproate injection) be withdrawn from the market…
(AGENPARL) – SILVER SPRING mar 04 aprile 2023 FDA authorizes Gohibic (vilobelimab) injection Fonte/Source: http://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-gohibic-vilobelimab-injection-treatment-covid-19